Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

AstraZeneca beta-blocker now available in U.S. for heart failure treatment

April 10, 2001

Bertek licenses beta-blocker nebivolol; new indications to be evaluated

April 9, 2001

Preclinical study results for JTV-519 discussed in Kyoto

April 9, 2001

Different doses of toborinone evaluated for electrophysiological effects in dogs

April 9, 2001

Cardioprotective effects of new antioxidant discussed at Kyoto meeting

April 9, 2001

Second-line antihypertensive combination therapy launched in U.S.

April 6, 2001

Senju prepares new chymase inhibitor series for use in cardiovascular disorders

April 3, 2001

Comprehensive review of Natrecor published in prestigious journal

April 3, 2001

Novel cardiovascular drugs sought by MediGene and Evotec BioSystems

April 3, 2001

ACS news: A-292438 as a promising ETA-selective antagonist

April 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...